Monday, June 15, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 310 of 1,261

  1. US 11135283

    Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids

    IMMUNE DESIGN CORP. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  2. US 11135280

    Modified ebolavirus glycoproteins comprising mutations in the head and base domains that increase antibody cross-reactivity

    INTEGRATED BIOTHERAPEUTICS, INC. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  3. US 11135267

    Etanercept formulations stabilized with metal ions

    Coherus BioSciences, Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  4. US 11135244

    Stem cell culture media and methods of enhancing cell survival

    Fate Therapeutics, Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  5. US 11135251

    Methods for improving fillet quality in farmed fish

    AKER BIOMARINE ANTARCTIC AS · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  6. US 11135236

    Retinoic acid receptor gamma agonists to attenuate anthracycline-induced cardiotoxicity

    Northwestern University · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  7. US 11135225

    Cancer treatments using combinations of CDK and ERK inhibitors

    Biomed Valley Discoveries, Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  8. US 11136384

    Methods for treatment of cancer comprising TIGIT-binding agents

    MEREO BIOPHARMA 5, INC. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  9. US 11135204

    Anhydrous compositions of mTOR inhibitors and methods of use

    PALVELLA THERAPEUTICS, INC. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  10. US 11135247

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  11. US 11135284

    MERS-CoV vaccine

    Inovio Pharmaceuticals, Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  12. US 11136301

    Broad spectrum antiviral compounds and uses thereof

    The Regents of the University of California, A California Corporation et al. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  13. US 11135222

    Aurora kinase inhibitors

    The Regents of the University of California · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  14. US 11136405

    BAFF-R antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  15. US 11135216

    Sublingual and buccal film compositions

    Indivior UK Limited · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  16. US 11135307

    Peptide-containing linkers for antibody-drug conjugates

    Mersana Therapeutics, Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  17. US 11135299

    Chemoselective modification of a carrier protein with a strained alkyne-labeled cargo agent

    The Regents of the University of California · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  18. US 11129841

    CD73 inhibitors

    ORIC PHARMACEUTICALS, INC. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  19. US 11130999

    Cas-ready mouse embryonic stem cells and mice and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  20. US 11130783

    CD40 targeted peptides and uses thereof

    Regents of the University of Minnesota · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  21. US 11130753

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  22. US 11129903

    Multispecific antigen-binding molecules and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  23. US 11129891

    Cytomegalovirus surface protein complex for use in vaccines and as a drug target

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

  24. US 11129859

    Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

    Finch Therapeutics Holdings LLC · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.